123 related articles for article (PubMed ID: 11444236)
1. Histological and genetic heterogeneity in synchronous hepatocellular carcinoma.
Cetta F; Zuckermann M; del Vecchio MT; Ercolani G; Mazziotti A
Gut; 2001 Jul; 49(1):155-6. PubMed ID: 11444236
[No Abstract] [Full Text] [Related]
2. KLF6 in nonalcoholic fatty liver disease: role of fibrogenesis and carcinogenesis.
Watanabe K; Ohnishi S; Manabe I; Nagai R; Kadowaki T
Gastroenterology; 2008 Jul; 135(1):309-12. PubMed ID: 18558090
[No Abstract] [Full Text] [Related]
3. [Clonal analysis of regenerating nodules in hepatitis C-induced liver cirrhosis].
Hensel F; Niederau C
Z Gastroenterol; 1995 Oct; 33(10):628-9. PubMed ID: 7502561
[No Abstract] [Full Text] [Related]
4. Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma.
Wojcicka A; Swierniak M; Kornasiewicz O; Gierlikowski W; Maciag M; Kolanowska M; Kotlarek M; Gornicka B; Koperski L; Niewinski G; Krawczyk M; Jazdzewski K
Int J Biochem Cell Biol; 2014 Aug; 53():208-17. PubMed ID: 24875649
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition in the liver.
Firrincieli D; Boissan M; Chignard N
Gastroenterol Clin Biol; 2010 Oct; 34(10):523-8. PubMed ID: 20615641
[TBL] [Abstract][Full Text] [Related]
6. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
Feng D; Zheng H; Shen M; Cheng R; Yan Y
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):325-8. PubMed ID: 12080637
[TBL] [Abstract][Full Text] [Related]
7. A case of juvenile hepatocellular carcinoma associated with liver cirrhosis in a family clustering of HBs antigen carriers and liver diseases.
Nunoda S; Mimo N; Kitano H; Kyoi M; Hifumi S; Ueno T; Takeda R; Nakanuma Y
Am J Gastroenterol; 1983 May; 78(5):301-4. PubMed ID: 6303115
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis C, EGFR, cirrhosis and netrin-1: potential implications for HCC onset].
Plissonnier ML; Lahlali T; Mehlen P; Parent R
Med Sci (Paris); 2016; 32(6-7):566-8. PubMed ID: 27406760
[No Abstract] [Full Text] [Related]
9. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
10. AgNORs count and DNA ploidy in liver biopsies from patients with schistosomal liver cirrhosis and hepatocellular carcinoma.
Attallah AM; Tabll AA; El-Nashar E; El-Bakry KA; El-Sadany M; Ibrahim T; El-Dosoky I
Clin Biochem; 2009 Nov; 42(16-17):1616-20. PubMed ID: 19682447
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis reveals potential candidate drugs for HCC.
Huang XB; Li J; Zheng L; Zuo GH; Han KQ; Li HY; Liang P
Pathol Oncol Res; 2013 Apr; 19(2):251-8. PubMed ID: 23341104
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic reprogramming in liver fibrosis and cancer.
Wilson CL; Mann DA; Borthwick LA
Adv Drug Deliv Rev; 2017 Nov; 121():124-132. PubMed ID: 29079534
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ).
Rawlings W; Moss J; Cooper HS; Hamilton SR
Ann Intern Med; 1974 Dec; 81(6):771-3. PubMed ID: 4372920
[No Abstract] [Full Text] [Related]
14. Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis.
Gao B; Zhang X; Huang Y; Yang Z; Zhang Y; Zhang W; Gao ZH; Xue D
PLoS One; 2017; 12(3):e0174142. PubMed ID: 28355233
[TBL] [Abstract][Full Text] [Related]
15. Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis.
Tannapfel A; Wittekind C
Virchows Arch; 2002 Apr; 440(4):345-52. PubMed ID: 11956813
[TBL] [Abstract][Full Text] [Related]
16. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease.
Valenti L; Dongiovanni P; Ginanni Corradini S; Burza MA; Romeo S
Dig Liver Dis; 2013 Aug; 45(8):619-24. PubMed ID: 23333103
[TBL] [Abstract][Full Text] [Related]
17. Familial active chronic hepatitis with hepatocellular carcinoma. Report of a case.
Joske RA; Laurence BH; Matz LR
Gastroenterology; 1972 Mar; 62(3):441-4. PubMed ID: 4334824
[No Abstract] [Full Text] [Related]
18. Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up.
Roncalli M; Bianchi P; Grimaldi GC; Ricci D; Laghi L; Maggioni M; Opocher E; Borzio M; Coggi G
Hepatology; 2000 Apr; 31(4):846-50. PubMed ID: 10733538
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma versus nonalcoholic fatty liver disease: metabolic, environmental, and genetic association? De facto?
Toman D; Sengul I; Pelikán A; Sengul D; Vavra P; Ihnát P; Roman J; Kayaalp C
Rev Assoc Med Bras (1992); 2022 May; 68(5):708-711. PubMed ID: 35584501
[No Abstract] [Full Text] [Related]
20. Role of the Hedgehog pathway in hepatocellular carcinoma (review).
Zheng X; Zeng W; Gai X; Xu Q; Li C; Liang Z; Tuo H; Liu Q
Oncol Rep; 2013 Nov; 30(5):2020-6. PubMed ID: 23970376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
